Download Traitement

Transcript
Réponse PASI 75 à 1an
6/10 Pat.
5/10 Pat.
5/10 Pat.
6/10 Pat.
80
%patients PASI 75
60
61 %
56 %
* 36 semaines
49 %
40
49 %*
45 %*
20
0
n = 45
Adalimumab1
40 mg/eow
1 x 80 mg induction
n = 339
Efalizumab2
n = 193
n = 194
Etanercept3
25 mg
n = 301
Infliximab4
50 mg→25 mg
5 mg/kg weekly 0, 2, 6;
every 8 weeks
BIW
1Gordon KB, et al. J Am Acad Dermatol. 2006;55 (4):598-606; 2Shear NH, et al. EADV 2005; FC13.15; 3Leonardi C, et al. AAD 2006; P2861; 4Reich K, et al. Lancet.
2005;366:1367-74 .